Absent in melanoma 2: a potent suppressor of retinal pigment epithelial-mesenchymal transition and experimental proliferative vitreoretinopathy

Abstract Epithelial-to-mesenchymal transition (EMT) is a critical and complex process involved in normal embryonic development, tissue regeneration, and tumor progression. It also contributes to retinal diseases, such as age-related macular degeneration (AMD) and proliferative vitreoretinopathy (PVR...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu Chen, Mingyuan Jiang, Liping Li, Shanshan Yang, Zuimeng Liu, Shiwen Lin, Wanxiao Wang, Jinyang Li, Feng Chen, Qiang Hou, Xiaoyin Ma, Ling Hou
Format: Article
Language:English
Published: Nature Publishing Group 2025-01-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-025-07367-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571232122306560
author Yu Chen
Mingyuan Jiang
Liping Li
Shanshan Yang
Zuimeng Liu
Shiwen Lin
Wanxiao Wang
Jinyang Li
Feng Chen
Qiang Hou
Xiaoyin Ma
Ling Hou
author_facet Yu Chen
Mingyuan Jiang
Liping Li
Shanshan Yang
Zuimeng Liu
Shiwen Lin
Wanxiao Wang
Jinyang Li
Feng Chen
Qiang Hou
Xiaoyin Ma
Ling Hou
author_sort Yu Chen
collection DOAJ
description Abstract Epithelial-to-mesenchymal transition (EMT) is a critical and complex process involved in normal embryonic development, tissue regeneration, and tumor progression. It also contributes to retinal diseases, such as age-related macular degeneration (AMD) and proliferative vitreoretinopathy (PVR). Although absent in melanoma 2 (AIM2) has been linked to inflammatory disorders, autoimmune diseases, and cancers, its role in the EMT of the retinal pigment epithelium (RPE-EMT) and retinal diseases remains unclear. The present study demonstrated that AIM2 functions as a potent suppressor of RPE cell proliferation and EMT to maintain retinal homeostasis. Transcriptome analysis using RNA-sequencing (RNA-Seq) revealed that AIM2 was significantly downregulated in primary human RPE (phRPE) cells undergoing EMT and proliferation. Consequently, Aim2-deficient mice showed morphological changes and increased FN expression in RPE cells under physiological conditions, whereas AIM2 overexpression in phRPE cells inhibited EMT. In a retinal detachment-induced PVR mouse model, AIM2 deficiency promotes RPE-EMT, resulting in severe experimental PVR. Clinical samples further confirmed the downregulation of AIM2 in the PVR membranes from patients. Kyoto Encyclopedia of Genes and Genome analysis revealed that the PI3K-AKT signaling pathway was significantly related to RPE-EMT and that AIM2 inhibited AKT activation in RPE cells by reducing its phosphorylation. Moreover, treatment with eye drops containing an AKT inhibitor alleviated RPE-EMT and the severity of experimental PVR. These findings provide new insights into the complex mechanisms underlying RPE-EMT and PVR pathogenesis, with implications for rational strategies for potential therapeutic applications in PVR by targeting RPE-EMT.
format Article
id doaj-art-4d340d0ca96b49f09ca8eb08b5019e1d
institution Kabale University
issn 2041-4889
language English
publishDate 2025-01-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj-art-4d340d0ca96b49f09ca8eb08b5019e1d2025-02-02T12:44:47ZengNature Publishing GroupCell Death and Disease2041-48892025-01-0116111310.1038/s41419-025-07367-9Absent in melanoma 2: a potent suppressor of retinal pigment epithelial-mesenchymal transition and experimental proliferative vitreoretinopathyYu Chen0Mingyuan Jiang1Liping Li2Shanshan Yang3Zuimeng Liu4Shiwen Lin5Wanxiao Wang6Jinyang Li7Feng Chen8Qiang Hou9Xiaoyin Ma10Ling Hou11Laboratory of Developmental Cell Biology and Disease, State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical UniversityLaboratory of Developmental Cell Biology and Disease, State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical UniversityLaboratory of Developmental Cell Biology and Disease, State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical UniversityLaboratory of Developmental Cell Biology and Disease, State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical UniversityLaboratory of Developmental Cell Biology and Disease, State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical UniversityLaboratory of Developmental Cell Biology and Disease, State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical UniversityLaboratory of Developmental Cell Biology and Disease, State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical UniversityNational Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical UniversityNational Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical UniversityState Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical UniversityLaboratory of Developmental Cell Biology and Disease, State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical UniversityLaboratory of Developmental Cell Biology and Disease, State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical UniversityAbstract Epithelial-to-mesenchymal transition (EMT) is a critical and complex process involved in normal embryonic development, tissue regeneration, and tumor progression. It also contributes to retinal diseases, such as age-related macular degeneration (AMD) and proliferative vitreoretinopathy (PVR). Although absent in melanoma 2 (AIM2) has been linked to inflammatory disorders, autoimmune diseases, and cancers, its role in the EMT of the retinal pigment epithelium (RPE-EMT) and retinal diseases remains unclear. The present study demonstrated that AIM2 functions as a potent suppressor of RPE cell proliferation and EMT to maintain retinal homeostasis. Transcriptome analysis using RNA-sequencing (RNA-Seq) revealed that AIM2 was significantly downregulated in primary human RPE (phRPE) cells undergoing EMT and proliferation. Consequently, Aim2-deficient mice showed morphological changes and increased FN expression in RPE cells under physiological conditions, whereas AIM2 overexpression in phRPE cells inhibited EMT. In a retinal detachment-induced PVR mouse model, AIM2 deficiency promotes RPE-EMT, resulting in severe experimental PVR. Clinical samples further confirmed the downregulation of AIM2 in the PVR membranes from patients. Kyoto Encyclopedia of Genes and Genome analysis revealed that the PI3K-AKT signaling pathway was significantly related to RPE-EMT and that AIM2 inhibited AKT activation in RPE cells by reducing its phosphorylation. Moreover, treatment with eye drops containing an AKT inhibitor alleviated RPE-EMT and the severity of experimental PVR. These findings provide new insights into the complex mechanisms underlying RPE-EMT and PVR pathogenesis, with implications for rational strategies for potential therapeutic applications in PVR by targeting RPE-EMT.https://doi.org/10.1038/s41419-025-07367-9
spellingShingle Yu Chen
Mingyuan Jiang
Liping Li
Shanshan Yang
Zuimeng Liu
Shiwen Lin
Wanxiao Wang
Jinyang Li
Feng Chen
Qiang Hou
Xiaoyin Ma
Ling Hou
Absent in melanoma 2: a potent suppressor of retinal pigment epithelial-mesenchymal transition and experimental proliferative vitreoretinopathy
Cell Death and Disease
title Absent in melanoma 2: a potent suppressor of retinal pigment epithelial-mesenchymal transition and experimental proliferative vitreoretinopathy
title_full Absent in melanoma 2: a potent suppressor of retinal pigment epithelial-mesenchymal transition and experimental proliferative vitreoretinopathy
title_fullStr Absent in melanoma 2: a potent suppressor of retinal pigment epithelial-mesenchymal transition and experimental proliferative vitreoretinopathy
title_full_unstemmed Absent in melanoma 2: a potent suppressor of retinal pigment epithelial-mesenchymal transition and experimental proliferative vitreoretinopathy
title_short Absent in melanoma 2: a potent suppressor of retinal pigment epithelial-mesenchymal transition and experimental proliferative vitreoretinopathy
title_sort absent in melanoma 2 a potent suppressor of retinal pigment epithelial mesenchymal transition and experimental proliferative vitreoretinopathy
url https://doi.org/10.1038/s41419-025-07367-9
work_keys_str_mv AT yuchen absentinmelanoma2apotentsuppressorofretinalpigmentepithelialmesenchymaltransitionandexperimentalproliferativevitreoretinopathy
AT mingyuanjiang absentinmelanoma2apotentsuppressorofretinalpigmentepithelialmesenchymaltransitionandexperimentalproliferativevitreoretinopathy
AT lipingli absentinmelanoma2apotentsuppressorofretinalpigmentepithelialmesenchymaltransitionandexperimentalproliferativevitreoretinopathy
AT shanshanyang absentinmelanoma2apotentsuppressorofretinalpigmentepithelialmesenchymaltransitionandexperimentalproliferativevitreoretinopathy
AT zuimengliu absentinmelanoma2apotentsuppressorofretinalpigmentepithelialmesenchymaltransitionandexperimentalproliferativevitreoretinopathy
AT shiwenlin absentinmelanoma2apotentsuppressorofretinalpigmentepithelialmesenchymaltransitionandexperimentalproliferativevitreoretinopathy
AT wanxiaowang absentinmelanoma2apotentsuppressorofretinalpigmentepithelialmesenchymaltransitionandexperimentalproliferativevitreoretinopathy
AT jinyangli absentinmelanoma2apotentsuppressorofretinalpigmentepithelialmesenchymaltransitionandexperimentalproliferativevitreoretinopathy
AT fengchen absentinmelanoma2apotentsuppressorofretinalpigmentepithelialmesenchymaltransitionandexperimentalproliferativevitreoretinopathy
AT qianghou absentinmelanoma2apotentsuppressorofretinalpigmentepithelialmesenchymaltransitionandexperimentalproliferativevitreoretinopathy
AT xiaoyinma absentinmelanoma2apotentsuppressorofretinalpigmentepithelialmesenchymaltransitionandexperimentalproliferativevitreoretinopathy
AT linghou absentinmelanoma2apotentsuppressorofretinalpigmentepithelialmesenchymaltransitionandexperimentalproliferativevitreoretinopathy